Climate change and tuberculosis: an analytical framework
Climate change is likely to exacerbate a range of determinants that drive tuberculosis,
the world's leading cause of death from a single infectious agent. However, tuberculosis
is often neglected in w...
Our framework that informed the @who.int TB & climate change policy brief out now in @lancetrespirmed.bsky.social, exploring the intersections and implications of climate change for the TB epidemic. Key message? TB should be considered a climate-sensitive disease
www.thelancet.com/journals/lan...
31.10.2025 09:12 โ ๐ 16 ๐ 13 ๐ฌ 1 ๐ 0
Announcement Awardees | TBVI Awards 2026 - TuBerculosis Vaccine Initiative
Announcement Awardees | TBVI Awards 2026
โจ Iโm so honoured to have been awarded one of this yearโs TBVI Awards! โจ
Iโm truly grateful for this recognition and excited for the opportunity to showcase my research at the TBVI Annual Meeting in January 2026.
#TBVI #tuberculosis #vaccines
tbvi.eu/announcement...
28.10.2025 13:24 โ ๐ 9 ๐ 1 ๐ฌ 0 ๐ 0
A global analysis of patterns of tuberculosis exposure and transmission
Tuberculosis (TB) is a major public health concern and the leading infectious cause of mortality globally. The disease exhibits strong prevalence patterns by age and sex, but the implications of these...
Understanding patterns of #TB exposure and transmission is needed for targeted prevention strategies. In our latest pre-print, @petedodd24.bsky.social and I estimated the proportion of TB exposure to and transmission from sex and age groups for 177 countries.
bit.ly/4nbV492
12.10.2025 12:51 โ ๐ 15 ๐ 17 ๐ฌ 1 ๐ 0
Differences in Tuberculosis Prevalence by Sex Over 1993-2024: A Systematic Review and Meta-Analysis
Background: Tuberculosis (TB) prevalence is higher among men than women in low- and middle-income countries (LMICs). However, summary measures of sex difference
1/ Itโs been 10 years (๐ฎ) since we reported that #TB prevalence was twice as high in men as in women.
๐ข Our new preprint explores how sex differences have shifted with more recent national prevalence surveys and growing attention to #gender responsive TB prevention and care.
bit.ly/4gqP1LH
16.09.2025 11:50 โ ๐ 8 ๐ 6 ๐ฌ 1 ๐ 1
The potential impact, cost and cost-effectiveness of tuberculosis interventions - a modelling exercise
Background While a range of interventions exist for tuberculosis prevention, screening, diagnosis, and treatment, their potential population impact and cost-effectiveness are seldom directly compared,...
At a time when global resources for #TB research, development, prevention, and care are limited, which interventions should be prioritised in high burden settings?
๐ข Our new pre-print compares the impact, cost, and cost-effectiveness of 9 TB interventions in 3 countries. 1/n
bit.ly/3V3vXth
05.09.2025 10:05 โ ๐ 11 ๐ 9 ๐ฌ 1 ๐ 0
Exploring trade-offs in diagnostic algorithm, population coverage, and duration of community screening for tuberculosis
Background Current tuberculosis (TB) prevention and care strategies have failed to reduce disease burden at the pace required to meet global targets. Community screening may enable more rapid declines...
Community screening for #tuberculosis could extend the reach of #TB services, but evidence on its effectiveness is limited.
In our latest preprint, we examine the epidemiological impact of trade-offs in diagnostic algorithm, population coverage, and duration of screening. 1/n
bit.ly/3UK7pFD
27.08.2025 14:55 โ ๐ 12 ๐ 7 ๐ฌ 1 ๐ 2
Reduced international donor funding through not only the termination of #USAID, but also announced reductions in donor pledges to #TheGlobalFund from other countries, could lead to substantial potential impacts on #TB morbidity and mortality.
Read how in our new study in @lancetgh.bsky.social ๐
15.07.2025 12:27 โ ๐ 7 ๐ 4 ๐ฌ 0 ๐ 0
Our work estimating the potential impacts of reductions in international donor funding for #TB is now out in @lancetgh.bsky.social:
bit.ly/3TDl28T
@raclark18.bsky.social @cfmcquaid.bsky.social @alexandra-richards.bsky.social @top-j.bsky.social @reinhouben.bsky.social @richardwhite321.bsky.social
14.07.2025 08:46 โ ๐ 13 ๐ 13 ๐ฌ 0 ๐ 2
New systematic review led by @hannahrickman.bsky.social shows annual risk of Mycobacterium #tuberculosis conversion in men and women diverges during adolescence and remains higher among men throughout adulthood.
www.thelancet.com/journals/lan...
02.07.2025 14:57 โ ๐ 5 ๐ 6 ๐ฌ 0 ๐ 0
Figure 1. Estimated number of trial endpoints in the control group of a prevention-of-disease vaccine trial in a high disease-burden setting showing number of endpoints on the y-axis and time in months on the x-axis. For bacteriologically confirmed symptomatic tuberculosis disease endpoints only, we estimate 69 endpoints, and for combined bacteriologically confirmed asymptomatic and symptomatic tuberculosis disease endpoints, we estimate 151 endpoints. Scenario assumes symptomatic disease incidence before trial screening of 300/100โ000 per year and following 10โ000 individuals over 3 years. Prevalent symptomatic and asymptomatic tuberculosis disease are screened out in month 0 and are not trial endpoints. Active screening occurs every 6 months for both scenarios and participants self-presenting with symptoms suggestive of tuberculosis disease would also be investigated.
In our latest personal view in @lancetrespirmed.bsky.social, we argue for the inclusion asymptomatic #tuberculosis in vaccine trial endpoints to potentially reduce the size, length, and cost of trials.
doi.org/10.1016/S221...
@lshtm-tbmod.bsky.social @tb-lshtm.bsky.social
04.07.2025 11:25 โ ๐ 14 ๐ 14 ๐ฌ 3 ๐ 0
Happening tomorrow! Come join us!
19.06.2025 13:00 โ ๐ 2 ๐ 1 ๐ฌ 0 ๐ 0
25th anniversary celebrations of the Introduction to Infectious Disease
Our special event will celebrate the 25th anniversary of the Introduction to Infectious Disease Modelling and its Applications course, delivered by the London School of Hygiene & Tropical Medicine
Can you believe itโs already been 25 years!?
Come join us on 20 June 2025 at 4pm UK time to celebrate the 25th anniversary of the Introduction to #Infectious Disease #Modelling course delivered by @lshtm.bsky.social and @ukhsa.bsky.social!
More info ๐ www.lshtm.ac.uk/newsevents/e...
28.05.2025 10:39 โ ๐ 8 ๐ 7 ๐ฌ 1 ๐ 3
Amid all the bad news in Global Health, perhaps some good news? A first analysis on the risk of false positive diagnoses in community-screening for tuberculosis using Xpert shows our clinic-based data is likely (very) wrong and overestimates false positives by >80%: tinyurl.com/yfecute9.
27.05.2025 14:50 โ ๐ 25 ๐ 10 ๐ฌ 3 ๐ 1
Postdoc (London, UK)
Position available in the world-leading tuberculosis (TB) Modelling group at LSHTM
with @raclark18.bsky.socialโฌ @richardwhite321.bsky.social
at LSHTM @lshtm-tbmod.bsky.social
More details: http://iddjobs.org/jobs/2314
20.05.2025 19:07 โ ๐ 6 ๐ 7 ๐ฌ 0 ๐ 0
Job Opportunity at LSHTM: Research Fellow
The London School of Hygiene & Tropical Medicine (LSHTM) is a world-leading centre for research and postgraduate education in public and global health. Our mission is to is to improve health and healt...
Are you interested in #TB and have experience in #modelling infectious diseases?
Come join us in the TB Modelling Group at #LSHTM!
We're advertising for a 1 year Research Fellow position, with a closing date of 30 May 2025 ๐ jobs.lshtm.ac.uk/vacancy.aspx...
16.05.2025 15:05 โ ๐ 10 ๐ 13 ๐ฌ 1 ๐ 1
๐Interested in finding out about #vaccine hesitancy?๐
Join us for our Annual Lecture on Monday 19 May for an opportunity to hear from Prof Stephan Lewandowsky @bristolunipsych.bsky.social & network with colleagues @lshtm.bsky.social & the Vaccine Centre.๐น๐ค
๐ www.lshtm.ac.uk/newsevents/e...
14.05.2025 14:58 โ ๐ 3 ๐ 2 ๐ฌ 0 ๐ 0
Our first #WorldImmunizationWeek podcast episode is live now!
Tune in to hear from @emprestige.bsky.social about their journey from MSc to PhD @lshtm.bsky.social. They also share insider tips on the best lunch spots in central London, so don't miss this.
soundcloud.com/user-7893872...
24.04.2025 09:06 โ ๐ 9 ๐ 6 ๐ฌ 0 ๐ 0
Table showing excess symptomatic TB episodes and excess TB deaths expected for different funding scenarios, including termination of USAID funding and reductions in Global Fund funding in line with expected reductions in donor countries' overseas development assistance.
Reductions in contributions to The Global Fund in line with current announcements by the United States, France, the United Kingdom, and Germany may lead to an additional 699,200, 63,100, 50,500, and 30,500 TB deaths, respectively. (See table for episodes of disease and other donor countries.) 4/8
27.04.2025 06:16 โ ๐ 5 ๐ 4 ๐ฌ 1 ๐ 0
Modelling projects the devastating impacts of US funding cuts, including our estimates of #TB incidence and deaths @lshtm-tbmod.bsky.social @tb-lshtm.bsky.social
22.04.2025 08:43 โ ๐ 12 ๐ 12 ๐ฌ 0 ๐ 0
๐๏ธ Coming up in May!
We are excited to welcome David Miles for our next seminar. This will cover a brief history of vaccinology, from Edward Jenner's first smallpox #vaccination to modern vaccine technology.
๐๏ธ 8 May
โฒ๏ธ 12.50 BST
๐LSHTM | Online
๐ www.lshtm.ac.uk/newsevents/e...
09.04.2025 09:06 โ ๐ 5 ๐ 3 ๐ฌ 0 ๐ 0
Line chart showing median number of TB deaths in 79 low- and middle-income countries from 2010 through 2040. A black line shows a decline from 1.25 million deaths in 2010 to just under 1 million deaths in 2024. A blue line shows the number of deaths staying constant through 2040 if 2024 funding and programmes are maintained. A red line shows the number of deaths increasing to 1.2 million in 2040 if US funding to national TB programmes is terminated.
New pre-print modelling impact of US funding cuts on HIV, #TB, MCH and family planning. We estimate impact of termination of US funding to NTPs via #USAID & The Global Fund may lead to 2.2 (1.5-2.9) million excess TB deaths between 2025 and 2040, reversing over a decade of progress.
bit.ly/4lowp18
09.04.2025 08:32 โ ๐ 31 ๐ 28 ๐ฌ 2 ๐ 2
Paediatric Infectious Diseases doctor and TBologist
๐ฌ Assistant Prof, Pathology โช@Duke | Director, Clin Micro Lab
๐งซ Former Clin Micro Fellow โช@Memorial Sloan Kettering
๐ฉ๐ปโ๐ฌ Former Postdoc @broadinstitute.org
๐ PhD @The Rockefeller University
Focus: Diagnostics, AMR, Structural Biology
Mathematical modeller in the TB modelling group at LSHTM
Public health physician and social epidemiologist passionate about addressing inequities in health and wellbeing through practice, research, and advocacy https://www.researchgate.net/profile/Matthew-Saunders-3?ev=hdr_xprf
Epidemiologist and infectious disease modeller @LSHTM
Global collab (https://www.javeriana.edu.co/, https://www.uniandes.edu.co/, @mrcunitgambia.bsky.social, @lshtm.bsky.social) developing a trustworthy data analysis ecosystem to get ahead of the next public health crisis.
๐ https://epiverse-trace.github.io/
Associate Prof of Medical Statistics @lshtm.bsky.social | TB and HIV treatment trialist | Electronic health records analyst | Running shoe geek
Treatment Action Group (TAG) is an independent, activist, and community-based research and policy think tank committed to racial, gender, and LGBTQ+ equity; social justice; and liberation, fighting to end HIV, TB, and hepatitis C virus (HCV).
The TB Community Coordination Hub brings together global voices of civil society, professionals, and the people and communities affected by Tuberculosis to unite to #EndTB.
https://www.tbcommunitycoordinationhub.com/
Founded in 1998, weโre a global network of over 300 researchers, postgraduate students, and support staff working together in 40 countries.
CITC @UCSF creates, enhances, and disseminates state-of-the-art resources and models of excellence to control and eliminate TB in the U.S. and Internationally
#Tuberculosis
The Vaccine Centre (VaC) is a collaborative partnership of over 100 scientists hosted by the London School of Hygiene & Tropical Medicine that aims to improve human and animal health through vaccination.
http://bit.ly/VaCHomepage
Health economist & ELSI scholar researching pediatric genomic medicine. Assistant Professor of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute. @cherpdpm.bsky.social
www.hadleysmith.com
Asst Prof @BUSPH Global Health | affiliate @decisionscience @HarvardChanSPH | @vaccineimpact and economic modeling | health equity | SFF nerd | she/her
One of the largest networks of TB experts in the world, harnessing diverse disciplinary expertise to end TB globally
Based at LSHTM, the Global Health Economics Centre is one of the world's largest groups of global #HealthEconomics academics from a variety of research disciplines.
Clinical Research & PhD in Molecular Biology
Tuberculosis, Global Health
ISGlobal, Barcelona (Spain)
MTBI, Manhiรงa (Mozambique)
Infectious disease modeller, associate professor at the London School of Hygiene and Tropical Medicine.